Statistics

Total Visits

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor11

Select a period of time:

Number of views in the range

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor3

Views

Views
July 20241
August 20240
September 20241
October 20241
November 20240
December 20240
January 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States2
United Kingdom1
 

Top cities views

Views
Prineville1